Francis C W, Marder V J
Annu Rev Med. 1986;37:187-204. doi: 10.1146/annurev.me.37.020186.001155.
Physiologic thrombolysis is efficient, while pathologic aberrations in the fibrinolytic system may result in either thrombotic or hemorrhagic disease. This review considers the molecular interactions involved in fibrinolysis, discusses the normal control mechanisms that provide for localized activation without systemic effects, and describes the molecular mechanism of plasmic degradation of fibrinogen and of cross-linked fibrin. The consequences of excessive or deficient fibrinolysis are discussed and specific examples cited of pathologic hemostasis directly related to abnormalities in the fibrinolytic system.
生理性溶栓是有效的,而纤溶系统的病理性异常可能导致血栓形成或出血性疾病。本综述考虑了纤溶过程中涉及的分子相互作用,讨论了能实现局部激活而无全身效应的正常控制机制,并描述了纤维蛋白原和交联纤维蛋白的血浆降解分子机制。文中讨论了纤溶过度或不足的后果,并列举了与纤溶系统异常直接相关的病理性止血的具体例子。